Muhammad Khalid Khan

Dr. Muhammad Khalid Khan

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2016 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
AHAbdul Hameed
Abdul Hameed
MAMariya Al-Rashida
Mariya Al-Rashida
MUMaliha Uroos
Maliha Uroos
SASyed Abid Ali
Syed Abid Ali
WVWolfgang Voelter
Wolfgang Voelter
Introduction: Schiff bases are synthetically accessible and structurally diverse compounds, typically obtained by facile condensation between an aldehyde, or a ketone with primary amines. Schiff bases contain an azomethine (-C = N-) linkage that stitches together two or more biologically active aromatic/heterocyclic scaffolds to form various molecular hybrids with interesting biological properties. Schiff bases are versatile metal complexing agents and have been known to coordinate all metals to form stable metal complexes with vast therapeutic applications. Areas covered: This review aims to provide a comprehensive overview of the various patented therapeutic applications of Schiff bases and their metal complexes from 2010 to 2015. Expert opinion: Schiff bases are a popular class of compounds with interesting biological properties. Schiff bases are also versatile metal complexing ligands and have been used to coordinate almost all d-block metals as well as lanthanides. Therapeutically, Schiff bases and their metal complexes have been reported to exhibit a wide range of biological activities such as antibacterial including antimycobacterial, antifungal, antiviral, antimalarial, antiinflammatory, antioxidant, pesticidal, cytotoxic, enzyme inhibitory, and anticancer including DNA damage.

29 December 2020 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
HYHafiza Amna Younus
Hafiza Amna Younus
MAMariya Al-Rashida
Mariya Al-Rashida
AHAbdul Hameed
Abdul Hameed
MUMaliha Uroos
Maliha Uroos
USUzma Salar
Uzma Salar
WVWolfgang Voelter
Wolfgang Voelter
Multicomponent reactions (MCR) have been utilized to synthesize a vast range of analogues belonging to diverse classes of heterocyclic compounds offering multidimensional pharmaceutical application...

1 April 2004 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
WVWolfgang Voelter
Wolfgang Voelter
SISajid Iqbal
Sajid Iqbal
MLMuhammad Arif Lodhi
Muhammad Arif Lodhi
GMGhulam Murtaza Maharvi
Ghulam Murtaza Maharvi
ZUZia- Ullah
Zia- Ullah
SPShahnaz Perveen
Shahnaz Perveen

5 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
SUSyed Muhammad Umer
Syed Muhammad Umer
MSMehwish Solangi
Mehwish Solangi
WVWolfgang Voelter
Wolfgang Voelter
RSRahman Saleem
Rahman Saleem
Indole alkaloids represent a large subset of natural products, with more than 4100 known compounds. The majority of these alkaloids are biologically active, with some exhibiting excellent antitumor, antibacterial, antiviral, antifungal, and antiplasmodial activities. Consequently, the natural products of this class have attracted considerable attention as potential leads for novel therapeutics and are routinely isolated, characterized, and profiled to gauge their biological potential. However, data on indole alkaloids, their various structures, and bioactivities are complex due to their diverse sources, such as plants, fungi, bacteria, sponges, tunicates, and bryozoans; thus, isolation methods produce an incredible trove of information. The situation is exacerbated when synthetic derivatives, as well as their structures, bioactivities, and synthetic schemes, are considered. Thus, to make such data comprehensive and inform researchers about the current field’s state, this review summarizes recent reports on novel indole alkaloids. It deals with the isolation and characterization of 250 novel indole alkaloids, a reappraisal of previously reported compounds, and total syntheses of indole alkaloids. In addition, several syntheses and semi-syntheses of indole-containing derivatives and their bioactivities are reported between January 2019 and July 2022.

1 November 2009 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
WVWolfgang Voelter
Wolfgang Voelter
MKMomin Khan
Momin Khan
MAMuhammad Ali
Muhammad Ali
MTMuhammad Taha
Muhammad Taha
SRSaima Rasheed
Saima Rasheed
MCMuhammad Iqbal Choudhary
Muhammad Iqbal Choudhary

1 June 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WVWolfgang Voelter
Wolfgang Voelter
FRFazal Rahim
Fazal Rahim
AWAbdul Wadood
Abdul Wadood
NKNaveen Kosar
Naveen Kosar
MTMuhammad Taha
Muhammad Taha
MCMuhammad Iqbal Choudhary
Muhammad Iqbal Choudhary